MedleyMed enters the U.S. market with a suite of digital health solutions
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Assam is home to more than 1,700 species of medicinal plants
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
Subscribe To Our Newsletter & Stay Updated